Hearing Loss Trial, Recruiting (NCT05402813)

Hearing Loss Trial, Recruiting NCT05402813 Sponsor: Sensorion Condition: Hearing Loss

Printed from Voxsanity (voxsanity.com.au) — NCT05402813 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hearing Loss

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Children aged 16 years or younger (for group 1) or 10 years or younger (for group 2) at the time consent is signed
Children diagnosed with hearing loss in both ears that is caused by the inner ear or hearing nerve (not by sound-blocking problems), ranging from mild to profound, and not linked to a broader syndrome
Children whose genetic test results show a change (mutation) in either the GJB2 or OTOF gene
Families who are able to provide written consent as required by local rules
Children who have no cochlear implant, or who have a cochlear implant in one or both ears

Who may not be able to join:

Children with other types of deafness, such as hearing loss in only one ear, ongoing hearing loss caused by sound-blocking problems, a physical malformation, a syndrome-related condition, or a known family history of deafness linked to genes other than OTOF or GJB2
Children whose genetic test results show a harmful change in a gene other than GJB2 or OTOF within the tested panel
Children or families who are unable or unwilling to follow all the requirements and procedures set out in the study plan

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Natalie LOUNDON, MD, Necker Hospital

Phone: +33 (0)7 86 31 13 76

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05402813

Sponsor: Sensorion

Phase: Not Applicable

Status: Recruiting

Condition: Hearing Loss

Trial contact: +33 (0)7 86 31 13 76

More information: https://clinicaltrials.gov/study/NCT05402813

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Children aged 16 years or younger (for group 1) or 10 years or younger (for group 2) at the time consent is signed
Children diagnosed with hearing loss in both ears that is caused by the inner ear or hearing nerve (not by sound-blocking problems), ranging from mild to profound, and not linked to a broader syndrome
Children whose genetic test results show a change (mutation) in either the GJB2 or OTOF gene
Families who are able to provide written consent as required by local rules
Children who have no cochlear implant, or who have a cochlear implant in one or both ears

Who may not be able to join:

Children with other types of deafness, such as hearing loss in only one ear, ongoing hearing loss caused by sound-blocking problems, a physical malformation, a syndrome-related condition, or a known family history of deafness linked to genes other than OTOF or GJB2
Children whose genetic test results show a harmful change in a gene other than GJB2 or OTOF within the tested panel
Children or families who are unable or unwilling to follow all the requirements and procedures set out in the study plan

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Sensorion

Registry

ClinicalTrials.gov

Start date

18 November 2022

Est. completion

1 June 2031

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Audiological characteristics; Electrophysiological characteristics: ABR; Electrophysiological characteristics: OAE

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov